# Cell Microsystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cell-microsystems

- Industry: Biotechnology
- Headquarters: Durham, US
- Website: http://www.cellmicrosystems.com
- Total disclosed funding: $6.5M
- Latest round: Series B (Aug 30, 2023)
- Investors on record: 1

## About

Based in North Carolina, US, and founded in 2010 headed by Gary Pace (CEO), Cell Microsystems, Inc. is a biotechnology firm that helps the user of its tool to view, find and differentiate viable single cells and clonal colonies. In November 2021 Cell Microsystems Inc has raised USD 10 million in an Unspecified round. The round was led by Telegraph Hill Partners (“THP”). The company’s customer base includes leading academic, government, and pharma organizations in the US and Europe.

The firm across a range of single-cell methodologies provides multiple discovery and development applications through its products CellRaft AIR System and CytoSort consumables. Its application also includes single-cell isolation, CRISPR gene editing, and track and trace clonal propagation. Additionally, the firm also provides genomics, stem cell propagation and programming, and the development of novel cell lines and organoids.

The company will use the November 2021 funding to accelerate commercial activity, develop new products, and expand the applications for single-cell characterization and isolation on the Company’s platforms.

## Funding rounds

- Series B, Aug 30, 2023, $6.5M — Telegraph Hill Partners

## Investors

- Telegraph Hill Partners (https://capitalatlas.ai/funds/telegraph-hill-partners) — Series B